BEATW
Heartbeam Inc. WarrantNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-0.49
Beta
—
52W High
$0.78
52W Low
$0.07
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Heartbeam Inc. Warrant
Heartbeam Inc. Warrant (BEATW) presents a compelling investment opportunity associated with Heartbeam Inc., an innovative healthcare technology company focused on enhancing cardiac diagnostics through advanced artificial intelligence and digital health solutions. The company’s platform is designed to significantly improve the precision of myocardial infarction diagnoses, thereby facilitating timely interventions that can lead to better patient outcomes. With the increasing demand for remote monitoring solutions in cardiovascular health, Heartbeam Inc. is poised to capitalize on the growth of the telehealth sector, making BEATW an attractive consideration for institutional investors seeking to invest in cutting-edge medical technology.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -164.20% |
| Return on Assets | -90.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.30 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $5.19M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/7/2026